Product Program year 2025 Source: CMS Open Payments

Cyanokit

Drug treatment of acute cyanide intoxication

NDC 50633-310-11

Open in the dashboard

General payments

$990,343

97 payments

Research payments

$0

0 payments

Through program year 2025, $990,343 in general payments and $0 in research payments were reported against Cyanokit (treatment of acute cyanide intoxication).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $53,015 20
2024 General $377,319 29
2023 General $203,248 27
2022 General $356,762 21

Breakdown

Who paid General payments · program years 2022–2025
  1. BTG International, Inc. $990,343 97 payments
Top recipients General payments · program year 2025
  1. Denver Health Medical Center Teaching hospital · CO $36,838 69% · 8 payments
  2. Timothy Babinchak Infectious Disease · Phoenixville, PA $3,750 7% · 1 payment
  3. Emory University Hospital Teaching hospital · GA $3,000 6% · 1 payment
  4. Ochsner Clinic Foundation Teaching hospital · LA $3,000 6% · 1 payment
  5. Christus Mother Frances Hosp-Tyler Teaching hospital · TX $2,500 5% · 1 payment

The top 5 of 12 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Infectious Disease Internal Medicine $3,750 96% · 1 practitioner
  2. Nurse Practitioner, Family Nurse Practitioner $77 2% · 1 practitioner
  3. Emergency Medical Services Emergency Medicine $57 1% · 1 practitioner
  4. Emergency Medicine $43 1% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Colorado $38,338 72% · 2 recipients
  2. Pennsylvania $3,827 7% · 2 recipients
  3. Louisiana $3,768 7% · 3 recipients
  4. Georgia $3,000 6% · 1 recipient
  5. Texas $2,526 5% · 2 recipients

The top 5 of 7 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

97 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record